Profitability
Weight: 15%
D-
30
- 5yr Avg ROIC -34.0%
- Operating Margin Trend +1113.52 pp/yr
RYTM
Rhythm Pharmaceuticals, Inc.
AlphaQuality composite grade, weighted for high-growth software businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -128.4%
- 5yr Share-Count CAGR 7.0%
Growth Quality
Weight: 35%
B-
68
- 5yr Revenue CAGR 178.5%
- 5yr EPS CAGR 0.0%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 20%
F
0
- 5yr FCF Margin -1175.6%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 10%
F
25
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) -8.52x
- Altman Z-Score 6.86
Stability
Weight: 5%
A-
80
- EPS Volatility (σ/μ) 0.00
- Piotroski F-Score 3
- Negative-Revenue Years (5) 0/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 3 gurus held; 2 added; 1 trimmed.
- Holders
- 3
- Avg Δ position
- +33.8%
- New buys
- 0
- Full exits
- 0
- Wood increased +97%
- Cooperman increased +4%
- Greenblatt decreased -0%